Turgut İlaçları A.Ş.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects (NCT04439929) | Turgut İlaçları A.Ş. | 2019-07-17 |
Track Turgut İlaçları A.Ş. automatically
Every clearance here is in the API, with alerts when new ones post.